🇺🇸 FDA
Patent

US 9738624

Nuclear transport modulators and uses thereof

granted A61PA61P11/00A61P17/02

Quick answer

US patent 9738624 (Nuclear transport modulators and uses thereof) held by Karyopharm Therapeutics Inc. expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Karyopharm Therapeutics Inc.
Grant date
Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61P, A61P11/00, A61P17/02, A61P25/00, A61P25/28